How Immunotherapy Treats Multiple Myeloma
Each year, as many as 33,000 people in the United States are diagnosed with multiple myeloma. This type of blood cancer originates in plasma cells, which are specific types of your immune system’s white blood cells that help fight off infections. In healthy individuals, plasma cells make antibodies, or special proteins, that help the body recognize and fend off foreign invaders and other harmful substances.
If you’ve been diagnosed, you may already know immunotherapy for multiple myeloma is a popular treatment choice. In many cases, immunotherapy is used in combination with standard cancer treatments like chemotherapy. One type of immunotherapy, stem cell transplantation from a donor, has been used for more than 30 years as a frontline treatment for those living with multiple myeloma.
Healthgrades Operating Company, Inc. All rights reserved. May not be reproduced
or reprinted without permission from Healthgrades Operating Company, Inc. Use
of this information is governed by the Healthgrades User Agreement.